Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Development and Validation of RP-HPLC Method for the Estimation of Raloxifene in Marketed Formulations

Development and Validation of RP-HPLC Method for the Estimation of Raloxifene in Marketed... Abstract A Simple, selective, accurate, economical reverse phase high performance liquid chromatography (RP-HPLC) was developed for estimation of Raloxifene in pharmaceutical formulations. Chromatographic separation achieved on a C18column (Use INERTSIL, C18, 5μ, 250 × 4.6 mm i.d.) with mobile phase containing acetonirile and ammonium acetate buffer in the ratio 75:25 v/v. The flow rate was 1.0 mL/min and effluent was monitored at 254 nm. The retention time was 4.413 min. The method was validated in terms of linearity, accuracy and precision. The linearity curve was found to be linear over 2.5 —12.5 μg/mL. The limit of detection and limit of quantification were found to be 0.0202 and 0.202 μg/ml respectively. The proposed method was successfully used to determine the drug content of marketed formulations. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Analytical Chemistry Letters Taylor & Francis

Development and Validation of RP-HPLC Method for the Estimation of Raloxifene in Marketed Formulations

Download PDF
5 pages

Development and Validation of RP-HPLC Method for the Estimation of Raloxifene in Marketed Formulations

Abstract

Abstract A Simple, selective, accurate, economical reverse phase high performance liquid chromatography (RP-HPLC) was developed for estimation of Raloxifene in pharmaceutical formulations. Chromatographic separation achieved on a C18column (Use INERTSIL, C18, 5μ, 250 × 4.6 mm i.d.) with mobile phase containing acetonirile and ammonium acetate buffer in the ratio 75:25 v/v. The flow rate was 1.0 mL/min and effluent was monitored at 254 nm. The retention time was 4.413 min. The method...
Loading next page...
 
/lp/taylor-francis/development-and-validation-of-rp-hplc-method-for-the-estimation-of-VMkzRI0C20
Publisher
Taylor & Francis
Copyright
Copyright Har Krishan Bhalla & Sons
ISSN
2230-7532
eISSN
2229-7928
DOI
10.1080/22297928.2012.10662620
Publisher site
See Article on Publisher Site

Abstract

Abstract A Simple, selective, accurate, economical reverse phase high performance liquid chromatography (RP-HPLC) was developed for estimation of Raloxifene in pharmaceutical formulations. Chromatographic separation achieved on a C18column (Use INERTSIL, C18, 5μ, 250 × 4.6 mm i.d.) with mobile phase containing acetonirile and ammonium acetate buffer in the ratio 75:25 v/v. The flow rate was 1.0 mL/min and effluent was monitored at 254 nm. The retention time was 4.413 min. The method was validated in terms of linearity, accuracy and precision. The linearity curve was found to be linear over 2.5 —12.5 μg/mL. The limit of detection and limit of quantification were found to be 0.0202 and 0.202 μg/ml respectively. The proposed method was successfully used to determine the drug content of marketed formulations.

Journal

Analytical Chemistry Letters – Taylor & Francis

Published: Jan 1, 2012

Keywords: Raloxifene; HPLC; linearity; validation

There are no references for this article.